Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6419
    -0.0007 (-0.10%)
     
  • OIL

    83.31
    +0.58 (+0.70%)
     
  • GOLD

    2,409.60
    +11.60 (+0.48%)
     
  • Bitcoin AUD

    100,269.09
    +1,628.95 (+1.65%)
     
  • CMC Crypto 200

    1,380.43
    +67.81 (+5.17%)
     
  • AUD/EUR

    0.6025
    -0.0006 (-0.10%)
     
  • AUD/NZD

    1.0902
    +0.0027 (+0.25%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,022.18
    -372.14 (-2.14%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • Dow Jones

    37,920.41
    +145.03 (+0.38%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

TREASURIES-U.S. yields rise as Pfizer vaccine update dents Omicron worry

By Chuck Mikolajczak

NEW YORK, Dec 8 (Reuters) - The benchmark U.S. 10-year Treasury yield rose for a third straight day on Wednesday, as drugmakers Pfizer and BioNtech announced positive results for their COVID-19 vaccine in a laboratory test against the new Omicron variant.

The companies said a three-shot course of the vaccine was shown to generate a neutralizing effect against the variant.

The yield on 10-year Treasury notes was up 3.3 basis points to 1.513%.

The yield on the 10-year had its biggest weekly drop since June 2020 last week after comments from Federal Reserve Chair Jerome Powell took a more hawkish tone and concerns over the Omicron variant rattled markets. The central bank is scheduled to hold its final policy meeting of the year next week.

ADVERTISEMENT

"What we are starting to see is a degree of migration away from a forced positioning in the wake of Omicron’s initial reporting plus month-end and we are in this shoulder period between that phenomenon and a really important signal from the Fed on Wednesday," said Eric Freedman, chief investment officer at U.S. Bank Wealth Management in Minneapolis.

The variant has been reported in 57 countries and the number of patients that will need hospitalization is likely to climb as it spreads, said the World Health Organization.

But comments from an official in South Africa and top U.S. infectious disease expert Dr. Anthony Fauci in recent days downplaying the severity of the variant have helped spur an appetite for risk, with the S&P 500 rising more than 3% in the past two trading sessions.

The U.S. Treasury will auction $36 billion in 10-year notes later on Wednesday. Analysts at Wells Fargo believe "the glut of cash in the financial system and persistent need for duration limits how poorly the auction can go."

The yield on the 30-year Treasury bond was up 5.3 basis points to 1.848%.

Later in the week, investors will get a look at the November consumer price index to gauge inflationary pressures.

The 6-month bill's yield touched 0.16% before backing off and was down 0.8 basis points to 1.513% as investors try to price in the first rate hike from the Fed.

A closely watched part of the U.S. Treasury yield curve measuring the gap between yields on two- and 10-year Treasury notes, seen as an indicator of economic expectations, was at 80.0 basis points.

The two-year U.S. Treasury yield, which typically moves in step with interest rate expectations, was up 2.2 basis points at 0.712%.

The breakeven rate on five-year U.S. Treasury Inflation-Protected Securities (TIPS) was last at 2.886%, after closing at 2.86% on Tuesday.

The 10-year TIPS breakeven rate was last at 2.534%, indicating the market sees inflation averaging 2.5% a year for the next decade.

The U.S. dollar 5 years forward inflation-linked swap , seen by some as a better gauge of inflation expectations due to possible distortions caused by the Fed's quantitative easing, was last at 2.409%. (Reporting by Chuck Mikolajczak; Editing by Andrea Ricci)